1. Home
  2. AXGN vs HRMY Comparison

AXGN vs HRMY Comparison

Compare AXGN & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axogen Inc.

AXGN

Axogen Inc.

HOLD

Current Price

$44.49

Market Cap

2.3B

Sector

Health Care

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$35.14

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXGN
HRMY
Founded
N/A
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
1.8B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
AXGN
HRMY
Price
$44.49
$35.14
Analyst Decision
Strong Buy
Buy
Analyst Count
9
9
Target Price
$42.33
$44.11
AVG Volume (30 Days)
1.2M
764.4K
Earning Date
04-28-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.97
EPS
N/A
0.55
Revenue
$225,208,000.00
$868,453,000.00
Revenue This Year
$20.57
$19.75
Revenue Next Year
$16.68
$12.88
P/E Ratio
N/A
$62.05
Revenue Growth
20.21
21.51
52 Week Low
$10.50
$25.52
52 Week High
$46.00
$40.87

Technical Indicators

Market Signals
Indicator
AXGN
HRMY
Relative Strength Index (RSI) 57.98 63.40
Support Level $29.48 $35.05
Resistance Level $44.83 $35.47
Average True Range (ATR) 2.34 1.13
MACD 0.05 0.02
Stochastic Oscillator 71.81 80.00

Price Performance

Historical Comparison
AXGN
HRMY

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: